Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Teduglutide
1.2.3 Linaclotide
1.2.4 Others
1.3 Market by Application
1.3.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Perspective (2018-2033)
2.2 Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Region
2.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Dynamics
2.3.1 Peptide Based Gastrointestinal Disorders Therapeutics Industry Trends
2.3.2 Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
2.3.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
2.3.4 Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue
3.1.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Based Gastrointestinal Disorders Therapeutics Revenue
3.4 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2022
3.5 Peptide Based Gastrointestinal Disorders Therapeutics Key Players Head office and Area Served
3.6 Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
3.7 Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Type
4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2024-2033)
5 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Application
5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2018-2033)
6.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2018-2023)
6.4 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2018-2033)
7.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2018-2023)
7.4 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2018-2033)
9.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.1.4 Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 Ironwood Pharmaceuticals
11.2.1 Ironwood Pharmaceuticals Company Detail
11.2.2 Ironwood Pharmaceuticals Business Overview
11.2.3 Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023)
11.2.5 Ironwood Pharmaceuticals Recent Development
11.3 Astellas Pharma
11.3.1 Astellas Pharma Company Detail
11.3.2 Astellas Pharma Business Overview
11.3.3 Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023)
11.3.5 Astellas Pharma Recent Development
11.4 Allergan
11.4.1 Allergan Company Detail
11.4.2 Allergan Business Overview
11.4.3 Allergan Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023)
11.4.5 Allergan Recent Development
11.5 Takeda Pharmaceutical
11.5.1 Takeda Pharmaceutical Company Detail
11.5.2 Takeda Pharmaceutical Business Overview
11.5.3 Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023)
11.5.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Teduglutide
Table 3. Key Players of Linaclotide
Table 4. Key Players of Others
Table 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2018-2023)
Table 9. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2024-2033)
Table 11. Peptide Based Gastrointestinal Disorders Therapeutics Market Trends
Table 12. Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
Table 13. Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
Table 14. Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints
Table 15. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2022)
Table 18. Ranking of Global Top Peptide Based Gastrointestinal Disorders Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
Table 22. Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application (2024-2033)
Table 32. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Takeda Company Detail
Table 48. Takeda Business Overview
Table 49. Takeda Peptide Based Gastrointestinal Disorders Therapeutics Product
Table 50. Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023) & (US$ Million)
Table 51. Takeda Recent Development
Table 52. Ironwood Pharmaceuticals Company Detail
Table 53. Ironwood Pharmaceuticals Business Overview
Table 54. Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Product
Table 55. Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023) & (US$ Million)
Table 56. Ironwood Pharmaceuticals Recent Development
Table 57. Astellas Pharma Company Detail
Table 58. Astellas Pharma Business Overview
Table 59. Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Product
Table 60. Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023) & (US$ Million)
Table 61. Astellas Pharma Recent Development
Table 62. Allergan Company Detail
Table 63. Allergan Business Overview
Table 64. Allergan Peptide Based Gastrointestinal Disorders Therapeutics Product
Table 65. Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Takeda Pharmaceutical Company Detail
Table 68. Takeda Pharmaceutical Business Overview
Table 69. Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Product
Table 70. Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Takeda Pharmaceutical Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Teduglutide Features
Figure 4. Linaclotide Features
Figure 5. Others Features
Figure 6. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2022 VS 2033
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Peptide Based Gastrointestinal Disorders Therapeutics Report Years Considered
Figure 12. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region: 2022 VS 2033
Figure 15. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players in 2022
Figure 16. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2022
Figure 18. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2018-2033)
Figure 20. United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2018-2033)
Figure 24. Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2018-2033)
Figure 32. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2018-2033)
Figure 40. Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2018-2033)
Figure 44. Turkey Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Takeda Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023)
Figure 47. Ironwood Pharmaceuticals Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023)
Figure 48. Astellas Pharma Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023)
Figure 49. Allergan Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023)
Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed